TickerFacts.

Altimmune, Inc. (ALT): Long-Term Debt

Annual figures by period end, from SEC filings.

$34.29M
As of 2025-12-31
$34.74M
As of 2026-06-30
2017-12-31: $599.9K2018-12-31: $572.8K2025-12-31: $34.29M$34.29M
2017-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$34.29Mn/a2026-03-06, Balance as of period end
No annual figure between 2018-12-31 and 2025-12-31.
2018-12-31$572.8K-4.5%2019-04-01, Balance as of period end
2017-12-31$599.9Kn/a2019-04-01, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Altimmune, Inc. (ALT)2025-12-31$34.29Mn/a
HCW Biologics Inc. (HCWB)2025-12-31$0-100.0%
Clene Inc. (CLNN)2025-12-31$17.79Mn/a
Scienture Holdings, Inc. (SCNX)2024-12-31$2.90Mn/a
Yarrow Bioscience, Inc. (YARW)2025-12-31$0n/a
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$109.59M+6.9%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$150.0K0.0%
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31$807.2K+27.8%
Northwest Biotherapeutics Inc (NWBO)2025-12-31$60.04M-4.2%

Compare ALT, HCWB, CLNN, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗